Sepetaprost demonstrated noninferiority to timolol 0.5% in decreasing intraocular pressure for patients with glaucoma or ocular hypertension.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback